Skip to main content

Articles

Page 51 of 51

  1. There is little data on the relationship between novel cardiovascular risk factors and silent coronary artery disease (CAD) in diabetic patients. We investigated whether Lipoprotein(a), homocysteine and apolip...

    Authors: Carmine Gazzaruso, Adriana Garzaniti, Stefano Giordanetti, Colomba Falcone and Pietro Fratino
    Citation: Cardiovascular Diabetology 2002 1:5
  2. The increase in the prevalence of insulin resistance-related metabolic syndrome, a disorder that greatly increases the risk of diabetes, heart attack and stroke, is alarming. One of the most frequent and early...

    Authors: Radka Lichnovská, Simona Gwozdziewiczová and Jirí Hrebícek
    Citation: Cardiovascular Diabetology 2002 1:4
  3. Metabolic syndrome, insulin resistance, prediabetes, and overt type 2 diabetes mellitus are associated with an accelerated atherosclerosis (atheroscleropathy). This quartet is also associated with multiple met...

    Authors: Melvin R Hayden and Suresh C Tyagi
    Citation: Cardiovascular Diabetology 2002 1:3
  4. The RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan) study is a multinational, double-blind, randomized, placebo controlled trial which was recently published. It was aimed ...

    Authors: Enrique Z Fisman, Alexander Tenenbaum and Michael Motro
    Citation: Cardiovascular Diabetology 2002 1:2

Cardiovascular Diabetology is affiliated with Sackler Faculty of Medicine, Tel-Aviv University

New Content Item

Annual Journal Metrics